Alembic Pharmaceuticals : Schedule of Analysts/Institutional Investor Meet/Con. Call
November 25, 2022 at 12:34 am EST
Share
Date: 25th November, 2022
To,
The Manager,
Listing Department,
National Stock Exchange of India Limited
"Exchange Plaza"
Bandra Kurla Complex, Bandra (E)
Mumbai - 400 051
Dear Sir/Madam,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Analyst / Investor Meeting
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the management of the Company shall be meeting analysts/investors through NBIE Virtual Investor Meeting hosted by Nirmal Bang Institutional Equities on 25th November, 2022.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
CHARANDEEP SINGH SALUJA
Digitally signed by CHARANDEEP SINGH SALUJA DN: c=IN, o=Personal, pseudonym=a60bda6662cacaa6dee424354752c8af2 17d06e3e0b6cc73c4bb1acdf09b43c5, postalCode=390008, st=GUJARAT, serialNumber=2df2425a9d726770b96178ea7d183d3 b13c8557e9c4be4aaf90236628eb533e7, cn=CHARANDEEP SINGH SALUJA
Alembic Pharmaceuticals Limited published this content on 25 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 November 2022 05:33:10 UTC.
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.